Denmark Asks Algeria To Cancel Investment Rule 51/49

Foreign Minister, Abdelkader Messahel, called on Danish businessmen, on Tuesday, to enter the Algerian market and invest in all fields, in partnership with Algerian private dealers, but they stipulated the abandonment of the investment base that organizes foreign investment in Algeria, and which was introduced in 2009 by Complementary Finance Law, as the delegation consisting of 50 Danish institutions defended the project of the Novo Nordisk laboratory in Algeria for the production of insulin, based in Boufarik, Blida, western Algeria.

Speaking at the opening of the Danish-Algerian Business Forum between the Forum of Heads of Institutions, and the Danish Employers’ Organization and the Danish Confederation of Industry, Messahel said that raising trade exchange between Algeria and Denmark is more than necessary, calling for new partnerships in the fields of Pharmaceutical Industry, Renewable Energies, Food Industries, Shipping and Logistics. 

He addressed the Danish institutions today: “Welcome to the Algerian market, but you have to produce, market and then export”, He also asked them to work with Algerian businessmen side by side.

For his part, the Danish Foreign Minister, Anders Samuelson described the investment opportunities in Algeria as very important. He encouraged the free investment initiative which the forum aims to promote by strengthening bilateral relationships in the economic and security sectors as well. 

“In Algeria, you have Danish institutions that are active since three decades ago”.

Denmark’s director of market development and international trade, Lens Holst-Nielsen, called for the elimination of the investment base that organizes foreign investments in Algeria, to ensure the entry of a large number of Danish enterprises to the Algerian market, although it does not pose a major obstacle at the current time, he said.

“But its removal will be more attractive to the Danes or other foreigners to enter the Algerian market and transfer their expertise, technology and experience”.

On Tuesday, the Economic Partnership laid the foundation stone for the completion of the insulin production complex in the city of Boufarik, as part of a partnership between SAIDAL and Novo Nordisk Complex by the Head of the Danish Diplomacy and the Health Minister, Mokhtar Hasbalaoui. 

Denmark is investing in Algeria through Novo Nordisk Laboratories in the framework of the National Pharmaceutical Complex SAIDAL for manufacturing the anti-diabetic drugs in Constantine and Tizi Ouzou.